Restorative Reproductive Medicine NaProTechnology

Chapter 90: The Future of NaProTECHNOLOGY

Hilgers TW

The Medical and Surgical Practice of NaProTECHNOLOGY, 2004

RRM Academy Synopsis

A NaProTECHNOLOGY textbook chapter calls for more training and trials

The closing chapter of the 2004 NaProTECHNOLOGY textbook calls for more practitioner training and more trials of the therapies it describes. The chapter presents a prototype charting system, outlines research topics, and proposes insurance reform.

Key Findings

  • The chapter describes the textbook's first 28 years of research as a first phase and quotes a 2002 lecture stating that evidence is lacking for about 85 percent of what physicians do.
  • The chapter states that the 13-month FertilityCare Practitioner training program must expand sizably over the next 5 to 10 years. The author also calls for centers of excellence and postgraduate fellowships.
  • The chapter presents a prototype hand-held system that interprets vaginal discharge recording system entries and gives feedback. A long-term version could link to a biochemical marker for fertility onset and postovulatory infertility.
  • The author states that laboratories need reference ranges established in different populations of women, and he calls for further studies of therapeutic claims, some of them double-blind, placebo-controlled trials.
  • The chapter's research topics include endometriosis causes, reproductive immunology, chronic stress, receptor deficiencies, preterm delivery, adhesion prevention, and long-term studies of bone density, breast cancer and endometrial cancer risk.

RRM Context

Restorative reproductive medicine (RRM) seeks the cause of a reproductive problem and works with the ovulatory cycle. NaProTECHNOLOGY, developed by Dr. Thomas W. Hilgers, applies that principle through cycle charting with the Creighton Model. The chapter contrasts cause-focused research with symptom suppression by oral contraceptives and with IVF, which bypasses the cause of infertility. Cycle charting supplies a woman's own biomarkers, so each evaluation begins from her real cycle data and the work remains cause-based. Under this approach the clinician asks why a problem occurs before choosing a treatment.

Abstract

This chapter outlines future work in NaProTECHNOLOGY, which the textbook presents as the first phase of 28 years of research. Areas it proposes include expanded CrMS practitioner training, computerized charting systems shown as prototypes, more uniform laboratory reference ranges, better adhesion prevention in surgery, and further research on premenstrual syndrome, osteoporosis, breast and endometrial cancer, infertility, endometriosis, chronic stress and prematurity. The chapter calls for additional studies, some of them double-blind, placebo-controlled trials of the therapeutic claims, conducted by physicians supportive of the treatment concepts. Closing sections address sociological evaluation of natural fertility regulation, insurance reform built around recognized centers of excellence, and protection of conscience for physicians and patients.

Read the guide

Topics

By this author

Related research

Restorative Reproductive Medicine › NaProTechnology › Protocols and Framework · Clinician Education and Training › Practice Adoption › Implementation in Practice
Thomas W Hilgers
Tom Hilgers, T Hilgers
Hilgers et al. 2004, Hilgers 2004